| Literature DB >> 24744692 |
Gauri Devi Bajju1, Sujata Kundan1, Madhulika Bhagat2, Deepmala Gupta1, Ashu Kapahi1, Geeta Devi1.
Abstract
Results of investigation of the physicochemical properties of zinc complexes containing substituted phenols as axial ligand having general formula [X-Zn-t(p-CH3) PP] [where X = different phenolates as axial ligand] in impurity-free organic solvent are presented. The four-coordinated zinc porphyrin accepts one axial ligand in 1 : 1 molar ratio to form five-coordinated complex, which is purified by column chromatography and characterized by physicochemical, biological evaluation and TGA/DTA studies. Absorption spectra show two principal effects: a red shift for phenols bearing substituted electron releasing groups (-CH3, -NH2) and blue shift for phenols bearing electron withdrawing groups (-NO2, -Cl) relative to Zn-t(p-CH3) PP, respectively. (1)H NMR spectra show that the protons of the phenol ring axially attached to the central metal ion are merged with the protons of the porphyrin ring. Fluorescence spectra show two fluorescence peaks in the red region with emission ranging from 550 nm to 700 nm. IR spectra confirm the appearance of Zn-NPor and Zn-O vibrational frequencies, respectively. According to the thermal studies, the complexes have a higher thermal stability and the decomposition temperature of these complexes depends on the axial ligation. The respective complexes of X-Zn(II)-t(p-CH3) PP were found to possess higher antifungal activity (up to 90%) and higher in vitro cytotoxicity against human cancer cells lines.Entities:
Year: 2014 PMID: 24744692 PMCID: PMC3976806 DOI: 10.1155/2014/782762
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1General synthetic route for the synthesis of zinc(II)-5,10,15,20-meso-tetra(para-methylphenyl)porphyrin containing different phenols as axial ligand.
1H NMR dataa of free base H2-t(p-CH3)PP and axially ligated X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) in CDCl3 at 298 K.
| Porphyrins |
| Imino protons |
| Other protons |
|---|---|---|---|---|
| H2t( | 8.86 (s) | −2.77 (s) | 8.11(d, 8H, H | 2.64(s, 12H, Hme) |
| Zn-t( | 8.65 (s) | — | 8.06(d, 8H, H | 2.69(s, 12H, Hme) |
| phO-Zn-t( | 8.99 (s) | — | 8.41(d, 10H, H | 2.71(s, 12H, Hme) |
|
| 9.2 (s) | — | 8.29(d, 10H, H | 2.9(s, 12H, Hme) |
|
| 8.93 (s) | — | 8.22(d, 10H, H | 2.31(s, 12H, Hme) |
|
| 8.90 (s) | — | 8.26(d, 10H, H | 2.36(s, 12H, Hme) |
| 2,4-Cl2phO-Zn-t( | 9.4 (s) | — | 8.33(d, 10H, H | 3.3(s, 12H, Hme) |
|
| 9.01 (s) | — | 8.39(d, 10H, H | 2.65(s, 12H, Hme) |
a δ in ppm; the nature of splitting pattern(s): (s = singlet, d = doublet, t = triplet, and m = multiplet); number of proton(s) and their location in the porphyrins, respectively, are given in parenthesis; o = ortho; p = para; m = meta.
Fluorescence spectral data of axially ligated compound of X-Zn-t(p-CH3)PP (X = different phenols as axial ligands) in methanol solvent using excitation at ~550 nm.
| Porphyrins |
|
|---|---|
| Zn-t( | 590, 640 |
|
| 612, 660 |
In vitro efficacy of axially ligated X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) against the pathogen Sclerotium rolfsi. Colony diameter of control C = 90 mm.
| Porphyrins | Different concentration | Colony diameter | % inhibition |
|---|---|---|---|
|
| 100 | 52.62 | 41.53 |
|
| |||
|
| 100 | 49.12 | 45.4 |
|
| |||
|
| 100 | 51 | 43.33 |
|
| |||
|
| 100 | 48 | 46.66 |
|
| |||
|
| 100 | 37.5 | 58.33 |
Figure 11H NMR spectra of p-NO2phO-Zn-t-(p-CH3)PP in CDCl3 at 298 K. Starred peaks are solvents impurities.
Figure 21H NMR spectra of p-OCH3phO-Zn-t-(p-CH3)PP in CDCl3 at 298 K. Starred peaks are solvents impurities.
Optical absorption data of X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) in CHCl3 showing λ max together with log ε and ν 1/2.
| Porphyrins | B-bands | Q-bands |
|---|---|---|
| H2t( | 430, (5.986), 989.4 | 516, 553, 592, 649 |
| Zn-t( | 432, (5.824), (995.3) | 564.2, (4.218), 789.3; |
| phO-Zn-t( | 430.2, (5.771), (997.9) | 563.8, (4.312), 785.1; |
|
| 431.4, (5.798), (1008) | 564.0, (4.418), 829.4; |
|
| 432, (5.833), (980.8) | 569.4, (4.484), 826.2; |
|
| 431.9, (5.845), (978.9) | 570.2, (4.521), 789.3; |
|
| 432.4, (5.808), (984.1) | 567, (4.448), 822.4; |
|
| 433.4, (5.806), (998) | 572.4, (4.527), 796.2; |
|
| 433.2, (5.696), (992.4) | 570.4, (4.456), 698.6; |
|
| 433.9, (5.859), (986.6) | 570.9, (4.432), 699.4; |
|
| 431, (5.964), (987.1) | 565, (4.643), 762.1; |
|
| 431.8, (5.839), (986.4) | 564, (4.682), 760.9; |
|
| 431.6, (5.969), (986.9) | 564, (4.861), 760.6; |
|
| 428, (5.942), (998.9) | 546, (4.549), 854.2; |
|
| 427, (5.841), (995.2) | 546, (4.643), 846.9; |
|
| 427, (5.872), (995.6) | 546, (4.516), 842.8; |
|
| 426, (5.646), (1014.4) | 547, (4.569), 872.3; |
|
| 425, (5.781), (992.5) | 548, (4.439), 781.9; |
|
| 425, (5.841), (998.6) | 548, (4.598), 785.2; |
Optical absorption data of X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) recorded in different solvents with calculated “f” values.
| Porphyrins | Solvent | B-band |
Q-bands |
Oscillator strength | ||
|---|---|---|---|---|---|---|
| Q (1, 0) | Q (0, 0) | B-band | Q-band | |||
|
| MtOH | 435.9, 714 | 589, 925 | 604, 531 | 0.140635 | 0.206755 |
| CHCl3 | 433.9, 437 | 570.9, 1096 | 604.6, 532 | 0.044387 | 0.253434 | |
| CH2Cl2 | 432.8, 542 | 568.4, 679 | 601, 740 | 0.0436727 | 0.1878264 | |
| CCl4 | 430, 631 | 560.1, 594 | 586, 447 | 0.115715 | 0.1331380 | |
|
| ||||||
|
| MtOH | 433.4, 615 | 564, 459 | 592, 525 | 0.19106399 | 0.0951163 |
| CHCl3 | 425, 750 | 548, 455 | 579, 549 | 0.1807739 | 0.0643726 | |
| CH2Cl2 | 424, 857 | 546, 426 | 573, 503 | 0.14803905 | 0.0757845 | |
| CCl4 | 422.8, 820 | 542, 561 | 568, 511 | 0.1416476 | 0.1341536 | |
|
| ||||||
|
| MtOH | 429, 686 | 584, 485 | 616.2, 555 | 0.0881638 | 0.1030306 |
| CHCl3 | 427, 770 | 546, 426 | 580, 463 | 0.2218310 | 0.0904969 | |
| CH2Cl2 | 427.8, 607 | 544.8, 470 | 577.4, 367 | 0.0838246 | 0.0852483 | |
| CCl4 | 424.4, 766 | 542.9, 540 | 540.2, 584 | 0.1439980 | 0.0572695 | |
Figure 3UV-Visible spectra of p-NH2phO-Zn-t(p-CH3)PP in different solvents.
Main vibrational frequencies corresponding to the various groups in X-Zn-t(p-CH3)PP (X = different phenols as axial ligand).
|
|
Mass data (m/z ratio) and elemental analytical data of X-Zn-t(p-CH3)PP (X = different phenols as axial ligand) along with their calculated values.
| Porphyrins | Molecular formula |
| Percentage | ||
|---|---|---|---|---|---|
| C | H | N | |||
| phO-Zn-t( | C54H41N4ZnO | 828.39 | 78.29 | 4.99 | 6.76 |
|
| C58H43N4ZnO | 878.90 | 79.31 | 4.94 | 6.38 |
|
| C54H43N5ZnO | 843.39 | 76.81 | 5.13 | 8.3 |
|
| C55H43N4ZnO2 | 858.53 | 76.94 | 5.05 | 6.53 |
|
| C54H40N4ZnOCl | 862.95 | 75.16 | 4.67 | 6.49 |
| 2,4Cl2phO-Zn-t( | C54H39N4ZnOCl2 | 897.39 | 72.27 | 4.38 | 6.24 |
Figure 4Fluorescence spectral data of Zn-t(p-CH3)PP and p-NH2phO-Zn-t(p-CH3)PP in methanol at excitation 550 nm.
Figure 5TG curve (a) and DTA curve (b) of p-OCH3phO-Zn-t(p-CH3)PP.
Figure 6(a) Antifungal activity of p-NH2phO-Zn-t(p-CH3)PP, (b) antifungal activity of p-OCH3phO-Zn-t(p-CH3)PP, (c) antifungal activity of p-NO2phO-Zn-t(p-CH3)PP, and (d) antifungal activity of p-ClphO-Zn-t(p-CH3)PP.
Figure 7In vitro cytotoxicity of p-NO2phO-Zn-t(p-CH3)PP complexes against human cancer cell lines.
Figure 8Proposed structure of axially ligated zinc(II) porphyrins.